title: Y253H mutation appearing in a micro-BCR-ABL (e19a2) CML.
authors.affiliation: Laboratoire d'Oncologie Moléculaire, INSERM UMR599 et Institut Paoli-Calmettes, Marseille, France.
authors.forename: Cornel
authors.initials: C
authors.lastname: Popovici
authors.forename: Aude
authors.initials: A
authors.lastname: Charbonnier
authors.forename: Olivier
authors.initials: O
authors.lastname: Gisserot
authors.forename: Philippe
authors.initials: P
authors.lastname: Aguilon
authors.forename: Virginie
authors.initials: V
authors.lastname: Rémy
authors.forename: Sylviane
authors.initials: S
authors.lastname: Olschwang
authors.forename: Marie-Joëlle
authors.initials: MJ
authors.lastname: Mozziconacci
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D000069439:Dasatinib; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D005260:Female; D016044:Fusion Proteins, bcr-abl / Q000235:genetics*; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000235:genetics*; D009154:Mutation; D010879:Piperazines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013844:Thiazoles / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D013844:Thiazoles; D000068877:Imatinib Mesylate; D016044:Fusion Proteins, bcr-abl; D000069439:Dasatinib